A review on herbal interventions and nanotechnological advancements for managing polycystic ovarian syndrome
Abstract
Objective: Polycystic ovarian syndrome (PCOS) is a condition caused by hormonal imbalance that can't be fully cured, but some symptoms can get better with changes in lifestyle, medications, and fertility treatments. This study aimed to evaluate the efficacy of herbal medicine on ovarian mass, weight, sex hormone disorders, and insulin resistance to treat PCOS. This disorder is mainly characterized by increased levels of androgens, acne, and hirsutism, and can lead to long-term insulin resistance, miscarriage, or even infertility in women. The present study reviews previous studies on the treatment of PCOS using natural drugs and nanotechnology used to treat PCOS.
Methods: A literature search was conducted in the scientific database using the keywords "polycystic ovary syndrome, phytoconstituents, and herbals". This review includes a collection of reports from Science Direct, Scholar Google, and PubMed were searched up to 2024. The results were assessed, gathered, and reported in this paper. A total of 162 papers were included, with an exponential growth in the number of articles published from 1980 to 2024.
Results: We discuss the significance of herbal remedies in treating PCOS, and the chemical composition, mechanism of action, and therapeutic application of selected herbal drugs against PCOS. These plant compounds can help PCOS patients by improving how their bodies process sugar and making them more sensitive to insulin.
Conclusions: The review suggested that future…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.